Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_3
1
25%
Ph phase_1
1
25%
Ph phase_2
2
50%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Other(3)

Detailed Status

unknown3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 31 (25.0%)

Trials by Status

unknown375%
not_yet_recruiting125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_3

A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid

NCT06221072
unknownphase_2

Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis

NCT05278338
unknownphase_2

Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis

NCT05397938
unknownphase_1

A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM

NCT04198480

Clinical Trials (4)

Showing 4 of 4 trials
NCT06221072Phase 3

A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid

Not Yet Recruiting
NCT05278338Phase 2

Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis

Unknown
NCT05397938Phase 2

Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis

Unknown
NCT04198480Phase 1

A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4